Document:

EX-10.24

 Exhibit 10.24 

*Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be competitively harmful if publicly disclosed.

  

													
	 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30
	 	 1. REQUISITION NUMBER

OS259397
	 	PAGE OF
	 	 	 	 	 	 	 	 	 	 	1	 	17

													
	 2. CONTRACT NO.

75A50120C00167
	 	 3. AWARD/ EFFECTIVE DATE
  

8/17/2020
	 	4. ORDER NUMBER	 	5. SOLICITATION NUMBER	 	6. SOLICITATION ISSUE DATE

													
	 7.  FOR
SOLICITATION
     INFORMATION CALL:

 
	 	 a. NAME

KIMBERLY GOLDEN
	 	b. TELEPHONE NUMBER	 	(No collect calls)	 	8. OFFER DUE DATE/LOCAL TIME

													
	9. ISSUED BY	 	CODE    	 	ASPR/SNS  	 	10. THIS ACQUISITION IS	 		 	 ☒ UNRESTRICTED OR
	 	☐ SET ASIDE:    %     FOR:
	  
 ASPR/SNS

ASPR/SNS
 2945 FLOWERS ROAD

ATLANTA, GA 30341
	 	 	 	 	 	  

☐ SMALL BUSINESS
  

☐ HUBZONE SMALL BUSINESS
  

☐ SERVICE-DISABLED VETERAN-OWNED SMALL BUSINESS
	 	 	 	  

☐ WOMEN-OWNED SMALL BUSINESS (WOSB) ELIGIBLE UNDER THE WOMEN-OWNED SMALL BUSINESS PROGRAM

 
 ☐ EDWOSB

 
 ☐ 8(A)

 
	 	  
 NAICS: 334510

 
 SIZE STANDARD: 1,250

															
	
11. DELIVERY FOR FOB DESTINATION UNLESS BLOCK IS MARKED

☒ SEE SCHEDULE
	 	12. DISCOUNT TERMS	 	
☐ 13a. THIS CONTRACT IS A RATED ORDER UNDER DPAS (15 CFR 700)
	 	 	 	13b. RATING
	 	 	 	 	 	 14. METHOD OF SOLICITATION

☐ RFQ                ☐
IFB            ☐ RFP

	15. DELIVER TO	 	CODE 	 	OS	 	 	 	16. ADMINISTERED BY	 	CODE 	 	ASPR/SNS
	  
 Office of the
Secretary
 200 Independence Ave. S.W.
 Washington DC
20201
	 	 	 	 	 	  
 US DEPT OF
HEALTH & HUMAN SERVICES
 ASPR/SNS
 2945 FLOWERS ROAD

ATLANTA, GA 30341x
  
	 	 
	 17a. CONTRACTOR/    CODE 

        OFFEROR
	 	1261480        	 	  FACILITY CODE	 	                	 	18a PAYMENT WILL BE MADE BY	 	CODE 	 	PSC
	  

OUTSET MEDICAL, INC.
 1830 BERING DR

SAN JOSE CA 951124212
  

TELEPHONE NO.          503-7029960
	 	  
 PSC

Program Support Center
 7700 Wisconsin Ave

Bethesda MD 20814
	 	
	☐ 17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER	 	 18c SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS
BLOCK BELOW
           IS
CHECKED            ☐ SEE ADDENDUM

													
	 19.

ITEM NO.
	 	 	 	 20.

SCHEDULE OF SUPPLIES/SERVICES
	 	21. QUANTITY	 	22. UNIT	 	 23.

UNIT PRICE
	 	 24.

AMOUNT

	 	 		 	Tax ID Number: 20-0514392	 	 	 	 	 	 	 	
	 	 		 	DUNS Number: 788744477	 	 	 	 	 	 	 	
	 	 		 	Delivery: 08/16/2022	 	 	 	 	 	 	 	
	 	 		 	Appr. Yr.: 2020 CAN: 199SN20 Object Class: 26067	 	 	 	 	 	 	 	
	 	 		 	Period of Performance: 08/17/2020 to 08/16/2022	 	 	 	 	 	 	 	
	 		 	 	 	 	
	 	 		 	Continued ...	 	 	 	 	 	 	 	
	 	 	 	 	(Use Reverse and/or Attach Additional Sheets as Necessary)	 	 	 	 	 	 	 	 

													
	 25. ACCOUNTING AND APPROPRIATION DATA

2020.199SN20.26067
	 	 	 	 	 	 	 	 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

$[***]

													
	 ☐ 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED.

☐ 27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR
52.212-5 IS ATTACHED.
  
	 		 		 		 	 ADDENDA    ☐ ARE        ☐ ARE NOT ATTACHED.

ADDENDA    ☐ ARE        ☐ ARE NOT
ATTACHED.

  

			
	
☒ 28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _____ COPIES TO ISSUING OFFICE. CONTRACTOR
AGREES TO FURNISH AND DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED.
	  	 ☐ 29. AWARD OF
CONTRACT: ____________ OFFER DATED ___________. YOUR OFFER ON SOLICITATION (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE SET FORTH HEREIN, IS ACCEPTED AS TO ITEMS:

	 30a. SIGNATURE OF OFFEROR/CONTRACTOR

/s/ Jamie Lewis
	  	 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

/s/ Kimberly L. Golden
  

													
	 30b NAME AND TITLE OF SIGNER (Type or print)

Jamie Lewis, Senior Vice President of Sales
	 	 	 	 30c DATE SIGNED

8/18/2020
	 	 31b. NAME OF CONTRACTING OFFICER (Type or print)

KIMBERLY L. GOLDEN
	 	 	 	 	 	31c. DATE SIGNED 8/19/2020

													
	AUTHORIZED FOR LOCAL REPRODUCTION	 	 	 	 	 	STANDARD FORM 1449 (REV. 2/2012)	 	 	 	 

 *Portions of this exhibit have been excluded because it both (i) is not material and
(ii) would be competitively harmful if publicly disclosed. 
  

			
	PREVIOUS EDITION IS NOT USABLE	 	Prescribed by GSA - FAR (48 CFR) 53.212

							
		  		  	
		  		  	
 2
 of 17

  

													
	 19.

ITEM NO.
	  	 20.

SCHEDULE OF SUPPLIES/SERVICES
	  	21.
QUANTITY    	  	22.
UNIT    	  	 23.

UNIT PRICE    
	  	 24.

        AMOUNT          

	1	  	 Dialysis Care Hemodialysis System Lease Dialysis System Refurbishd Units (monthly lease for 24 months)

 
 $[***] Monthly Payment

 
 The contractor shall provide [***] new or refurbished Portable Dialysis Machines at up
[***] USG-defined CONUS or OCONUS Locations
  

[***] - Refurbished at $[***]/month
  

[***] - New at $[***]/month
  

Obligated Amount: $[***]
	  	 	  	 	  	 	  	[***]
		 	 	 	 	 
	2	  	 24 Months Routine Maintenance

 
 $[***] Monthly Payment

 
 Provided by contractor within up to [***]
USG-defined CONUS or OCONUS locations Includes weekly chemical disinfection, filter replacement and other routine maintenance as required.

 
 Obligated Amount: $[***]

 
 Continued ...
	  	 	  	 	  	 	  	[***]

 32a. QUANTITY IN
COLUMN 21 HAS BEEN 
 ☐ RECEIVED            ☐
INSPECTED            ☐ ACCEPTED, AND CONFORMS TO THE CONTRACT, EXCEPT AS NOTED:
                     
  

													
	32b. SIGNATURE OF AUTHORIZED GOVERNMENT REPRESENTATIVE	  	32c. DATE	  	
32d. PRINTED NAME AND TITLE OF AUTHORIZED GOVERNMENT REPRESENTATIVE

	32e. MAILING ADDRESS OF AUTHORIZED GOVERNMENT REPRESENTATIVE	  	 32f  TELEPHONE
NUMBER OF AUTHORIZED GOVERNMENT REPRESENTATIVE

	 	  	 	  	 	  	 32g  E-MAIL OF
AUTHORIZED GOVERNMENT REPRESENTATIVE

	33. SHIP NUMBER	  	34. VOUCHER NUMBER	  	35. AMOUNT VERIFIED  	  	36. PAYMENT	  	37. CHECK NUMBER
	 	  		  	CORRECT FOR	  		  		  		  	
	☐ PARTIAL         ☐ FINAL	  	 	  	 	  	
☐ COMPLETE         ☐ PARTIAL        ☐ 
FINAL
  
	  	 
	38. S/R ACCOUNT NUMBER	  	39. S/R VOUCHER NUMBER	  	40. PAID BY	  	 	  	 	  	 	  	 
	  
 41a. I CERTIFY THIS
ACCOUNT IS CORRECT AND PROPER FOR PAYMENT
	  	42a. RECEIVED BY (Print)
	41b. SIGNATURE AND TITLE OF CERTIFYING OFFICER	  	41c. DATE	  	
		  		  		  	  

42b RECEIVED AT (Location)

	 	  	 	  	 	  	42c DATE REC’D (YY/MM/DD)	  	42d TOTAL CONTAINERS

 STANDARD FORM 1449 (REV. 2/2012) BACK 

 *Portions of this exhibit have been excluded because it both (i) is not material and
(ii) would be competitively harmful if publicly disclosed. 
  

							
	CONTINUATION SHEET        	  	 REFERENCE NO. OF DOCUMENT BEING CONTINUED

75A50120C00167
	  	PAGE OF
	 	  	 	  	
 3
    	  	17

 NAME OF OFFEROR OR CONTRACTOR 

OUTSET MEDICAL, INC 1261480 
  

													
	
  ITEM NO.  

(A)
	 	
SUPPLIES/SERVICES
 (B)
	  	 QUANTITY    

(C)    
	  	
UNIT    

(D)    
	  	
UNIT PRICE    

(E)    
	  	
AMOUNT    

(F)    
	 
	3	 	 Field Mainteance x 24 mos.
  

$[***] Monthly Payment
  

Provide maintenance of up to [***] systems in up to USG-defined [***] CONUS or OCONUS locations, or components shipped
to central depot(s)for repair. Contractor must maintain an operational availability of at least [***]%.
  

Obligated Amount: $[***]
	  		  	 	  		  	 	[***]	 
		 		 		 
	4	 	 Training & Curriculum up to [***] sites 24 months

 
 $[***] Monthly Payment

 
 Develop and deliver curricula for healthcare providers (inclusive of credentialed
personnel and technicians) for operation and care of portable dialysis technologies.
  

Obligated Amount: $[***]
	  		  	 	  		  	 	[***]	 
		 		 		 
	5	 	 Shipping and Delivery of Dialysis

 
 1 Job $[***]

 
 Care Hemodialysis System (CLIN 0001) The contractor shall ship and delivery of [***]
Dialysis Systems and ancillary materials to CONUS (US Territory) locations.
  
 OCONUS
Rates, See CLIN 9 for OCONUS rates)
  
 Obligated Amount: $[***]
	  		  	 	  		  	 	[***]	 
		 		 		 
	7	 	 Hemodialysis Consumables

 
 1 Job $[***]

 
 Shipping and Delivery Surge for delivery Dialysis Systems and ancillary materials to
CONUS and (US Territory) locations.
  
 Amount: $0.00 (Option Line Item)

 
 Continued ...
	  	 	  	 	  	 	  	 	0.00	 

			
	NSN 7540-01-152-8067	  	OPTIONAL FORM 336 (4-86)
		  	Sponsored by GSA
		  	FAR (48 CFR) 53.110

 *Portions of this exhibit have been excluded because it both (i) is not material and
(ii) would be competitively harmful if publicly disclosed. 
  

							
	CONTINUATION SHEET        	  	 REFERENCE NO. OF DOCUMENT BEING CONTINUED

75A50120C00167
	  	PAGE OF
	 	  	 	  	
 4
    	  	17

 NAME OF OFFEROR OR CONTRACTOR 

OUTSET MEDICAL, INC 1261480 
  

													
	
  ITEM NO.  

(A)
	  	
SUPPLIES/SERVICES
 (B)
	  	 QUANTITY    

(C)    
	  	
UNIT    

(D)    
	  	
UNIT PRICE    

(E)    
	  	
AMOUNT    

(F)    
	 
	8	  	 Hemodialysis Consumables
  

1 Job $[***]
  

Shipping and Delivery Surge for delivery Dialysis Systems and ancillary materials to OCONUS (US Territory) locations.

 
 Amount: $0.00 (Option Line Item)
	  		  	 	  		  	 	0.00	 
		 		 		 
	9	  	 Shipping and Delivery for OCONUS Shipments (CLIN 0001) for delivery of
Dialysis Systems and ancillary materials to OCONUS (US Territory) locations. This is an additional charge to that in CLIN 0005 for OCONUS delivery.
  

Total OCONUS delivery is $[***] / device Amount: $0.00 (Option Line Item) Optional Quantity Increase

 
 The government has taken a precautionary maximum quantity approach due to the
unpredictableness of national events. We cannot accurately predict the scope and timing of a national event such as a natural disaster. This approach ensures that the government has a viable surge option available should the Government require
additional services. In reference to FAR 52.217-6, the total allowable increased quantity shall not exceed [***]% of the total contract value. The Government may require the delivery of delivery of services
under CLIN?s 0006,0007, 0008 & 0009 as option items, in incremental quantities at the price stated in the award.
	  	 	  	 	  	 	  	 	0.00	 

			
	NSN 7540-01-152-8067	  	OPTIONAL FORM 336 (4-86)
		  	Sponsored by GSA
		  	FAR (48 CFR) 53.110

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

 SECTION C - CONTRACT CLAUSES 

C.1 FAR 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998) 

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting
Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es): 

http://www.acquisition.gov 
 (End of Clause) 

 

			
	 FAR SOURCE
	  	 TITLE AND DATE

	52.212-1	  	 Instructions to Offeror – Commercial Items (Jun 2020)

	52.212-3	  	 Offeror Representations and Certifications – Commercial Items (Jun 2020)

	52.212-4	  	 Contract Terms and Conditions – Commercial Items (Oct 2018)

	52.245-1	  	 Government Property (Jan 2017)

	52.247-34	  	 F.O.B. Destination (Nov 1991)

 Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Aug 2020) 

The Contractor shall comply with the following Federal Acquisition Regulation (FAR) clauses, which are incorporated in this contract by reference, to
implement provisions of law or Executive orders applicable to acquisitions of commercial items: 
 52.203-19,
Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (Jan 2017) (section 743 of Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L.
113-235) and its successor provisions in subsequent appropriations acts (and as extended in continuing resolutions)). 

52.204-23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky
Lab and Other Covered Entities (Jul 2018) (Section 1634 of Pub. L. 115-91). 

52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or
Equipment. (Aug 2020) (Section 889(a)(1)(A) of Pub. L. 115-232). 

52.209-10, Prohibition on Contracting with Inverted Domestic Corporations (Nov 2015). 

52.233-3, Protest After Award (Aug 1996) (31 U.S.C. 3553). 

52.233-4, Applicable Law for Breach of Contract Claim (Oct 2004) (Public Laws
108-77 and 108-78 (19 U.S.C. 3805 note)). 
 The Contractor
shall comply with the FAR clauses in this paragraph (b) that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial
items: 
 [Contracting Officer check as appropriate.] 
 X__
(1) 52.203-6, Restrictions on Subcontractor Sales to the Government (June 2020), with Alternate I (Oct 1995) (41 U.S.C. 4704 and 10 U.S.C. 2402). 

X__ (2) 52.203-13, Contractor Code of Business Ethics and Conduct (Jun 2020)
(41 U.S.C. 3509)). 

  
 5 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

 X__ (3) 52.203-15, Whistleblower Protections under the
American Recovery and Reinvestment Act of 2009 (Jun 2010) (Section 1553 of Pub. L. 111-5). (Applies to contracts funded by the American Recovery and Reinvestment Act of 2009.) 

X__ (4) 52.204-10, Reporting Executive Compensation and First-Tier Subcontract Awards (Jun 2020) (Pub. L. 109-282) (31 U.S.C. 6101 note). 
 __ (5) [Reserved]. 

__ (6) 52.204-14, Service Contract Reporting Requirements (Oct 2016) (Pub. L. 111-117, section 743 of Div. C). 
 __ (7) 52.204-15, Service Contract
Reporting Requirements for Indefinite-Delivery Contracts (Oct 2016) (Pub. L. 111-117, section 743 of Div. C). 
 X__
(8) 52.209-6, Protecting the Government’s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment. (Jun 2020) (31 U.S.C. 6101 note). 

X__ (9) 52.209-9, Updates of Publicly Available Information Regarding Responsibility Matters (Oct 2018)
(41 U.S.C. 2313). 
 __ (10) [Reserved]. 

__ (11) 52.219-3, Notice of HUBZone Set-Aside or Sole-Source Award (Mar
2020) (15 U.S.C. 657a). 
 __ (ii) Alternate I (Mar 2020) of 52.219-3. 

__ (12) 52.219-4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns (Mar 2020) (if
the offeror elects to waive the preference, it shall so indicate in its offer) (15 U.S.C. 657a). 
 __ (ii) Alternate I (Mar 2020) of
52.219-4. 
 __ (13) [Reserved] 

__ (14) 52.219-6, Notice of Total Small Business Set-Aside (Mar
2020) of 52.219-6 (15 U.S.C. 644). 
 __ (ii) Alternate I (Mar 2020) of 52.219-6. 
 __ (15) 52.219-7, Notice of Partial Small Business Set-Aside (Mar 2020) (15 U.S.C. 644). 
 __ (ii) Alternate I (Mar 2020) of 52.219-7. 
 __ (16) 52.219-8, Utilization of Small Business
Concerns (Oct 2018) (15 U.S.C. 637(d)(2) and (3)). 
 __ (17) 52.219-9, Small Business
Subcontracting Plan (Jun 2020) (15 U.S.C. 637(d)(4)). 
 __ (ii) Alternate I (Nov 2016) of
52.219-9. 
 __ (iii) Alternate II (Nov 2016) of 52.219-9.

 __ (iv) Alternate III (Jun 2020) of 52.219-9. 

__ (v) Alternate IV (Jun 2020) of 52.219-9. 

__ (18) 52.219-13, Notice of Set-Aside of Orders (Mar 2020)
(15 U.S.C. 644(r)). Alternate I (Mar 2020) of 52.219-13. 
 X__ (19) 52.219-14, Limitations on Subcontracting (Mar 2020) (15 U.S.C. 637(a)(14)). 
 __ (20) 52.219-16, Liquidated Damages-Subcontracting Plan (Jan 1999) (15 U.S.C. 637(d)(4)(F)(i)). 
 __
(21) 52.219-27, Notice of Service-Disabled Veteran-Owned Small Business Set-Aside (Mar 2020) (15 U.S.C. 657f). 

__ (22) 52.219-28, Post Award Small Business Program Rerepresentation (May 2020)
(15 U.S.C. 632(a)(2)). Alternate I (MAR 2020) of 52.219-28. 
 __ (23) 52.219-29, Notice of Set-Aside for, or Sole Source Award to, Economically Disadvantaged Women-Owned Small Business Concerns (Mar 2020) (15 U.S.C. 637(m)).

  
 6 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

 __ (24) 52.219-30, Notice of Set-Aside for, or Sole Source Award to, Women-Owned Small Business Concerns Eligible Under the Women-Owned Small Business Program (Mar 2020) (15 U.S.C. 637(m)). 

__ (25) 52.219-32, Orders Issued Directly Under Small Business Reserves (Mar 2020)
(15 U.S.C. 644(r)). 
 __ (26) 52.219-33, Nonmanufacturer Rule (Mar 2020) (15
U.S.C. 637(a)(17)). 
 X__ (27) 52.222-3, Convict Labor (Jun 2003) (E.O.11755). 

X__ (28) 52.222-19, Child Labor-Cooperation with Authorities and Remedies (Jan 2020) (E.O.13126). 

X__ (29) 52.222-21, Prohibition of Segregated Facilities (Apr 2015). 

X__ (30) 52.222-26, Equal Opportunity (Sep 2016) (E.O.11246). 

__ (ii) Alternate I (Feb 1999) of 52.222-26. 

__ (31) 52.222-35, Equal Opportunity for Veterans (Jun 2020) (38 U.S.C. 4212). 

__ (ii) Alternate I (Jul 2014) of 52.222-35. 

__ (32) 52.222-36, Equal Opportunity for Workers with Disabilities (Jun 2020)
(29 U.S.C. 793). 
 __ (ii) Alternate I (Jul 2014) of 52.222-36. 

__ (33) 52.222-37, Employment Reports on Veterans (Jun 2020) (38 U.S.C. 4212). 

__ (34) 52.222-40, Notification of Employee Rights Under the National Labor Relations Act (Dec 2010) (E.O.
13496). 
 X__ (35) 52.222-50, Combating Trafficking in Persons (Jan 2019)
(22 U.S.C. chapter 78 and E.O. 13627). 
 __ (ii) Alternate I (Mar 2015) of
52.222-50 (22 U.S.C. chapter 78 and E.O. 13627). 
 __ (36) 52.222-54, Employment Eligibility Verification (Oct 2015). (Executive Order 12989). (Not applicable to the acquisition of commercially available
off-the-shelf items or certain other types of commercial items as prescribed in 22.1803.) 

__ (37) 52.223-9, Estimate of Percentage of Recovered Material Content for EPA–Designated Items
(May 2008) (42 U.S.C. 6962(c)(3)(A)(ii)). (Not applicable to the acquisition of commercially available off-the-shelf items.) 

__ (ii) Alternate I (May 2008) of 52.223-9 (42 U.S.C. 6962(i)(2)(C)). (Not applicable
to the acquisition of commercially available off-the-shelf items.) 
 __
(38) 52.223-11, Ozone-Depleting Substances and High Global Warming Potential Hydrofluorocarbons (Jun 2016) (E.O. 13693). 

__ (39) 52.223-12, Maintenance, Service, Repair, or Disposal of Refrigeration Equipment and Air
Conditioners (Jun 2016) (E.O. 13693). 
 __ (40) 52.223-13, Acquisition of EPEAT®-Registered Imaging Equipment (Jun 2014) (E.O.s 13423 and 13514). 
 __
(ii) Alternate I (Oct 2015) of 52.223-13. 
 __
(41) 52.223-14, Acquisition of EPEAT®-Registered Televisions (Jun 2014) (E.O.s 13423 and 13514). 

__ (ii) Alternate I (Jun 2014) of 52.223-14. 

__ (42) 52.223-15, Energy Efficiency in Energy-Consuming Products (May 2020)
(42 U.S.C. 8259b). 
 __ (43) 52.223-16, Acquisition of EPEAT®-Registered Personal Computer Products (Oct 2015) (E.O.s 13423 and 13514). 
 __
(ii) Alternate I (Jun 2014) of 52.223-16. 

  
 7 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

 X__ (44) 52.223-18, Encouraging Contractor Policies to
Ban Text Messaging While Driving (Jun 2020) (E.O. 13513). 
 __ (45) 52.223-20, Aerosols (Jun 2016) (E.O.
13693). 
 __ (46) 52.223-21, Foams (Jun2016) (E.O. 13693). 

__ (47) 52.224-3 Privacy Training (Jan 2017) (5 U.S.C. 552 a). 

__ (ii) Alternate I (Jan 2017) of 52.224-3. 

__ (48) 52.225-1, Buy American-Supplies (May 2014) (41 U.S.C. chapter 83). 

__ (49) 52.225-3, Buy American-Free Trade Agreements-Israeli Trade Act (May 2014) (41 U.S.C.
chapter 83, 19 U.S.C. 3301 note, 19 U.S.C. 2112 note, 19 U.S.C. 3805 note, 19 U.S.C. 4001 note, Pub. L. 103-182, 108-77, 108-78, 108-286, 108-302, 109-53, 109-169, 109-283, 110-138, 112-41, 112-42, and 112-43. 
 __ (ii) Alternate I (May 2014) of 52.225-3. 

__ (iii) Alternate II (May 2014) of 52.225-3. 

__ (iv) Alternate III (May 2014) of 52.225-3. 

__ (50) 52.225-5, Trade Agreements (Oct 2019) (19 U.S.C. 2501, et seq.,
19 U.S.C. 3301 note). 
 __ (51) 52.225-13, Restrictions on Certain Foreign Purchases
(Jun 2008) (E.O.’s, proclamations, and statutes administered by the Office of Foreign Assets Control of the Department of the Treasury). 
 __ (52) 52.225-26, Contractors Performing Private Security Functions Outside the United States (Oct 2016) (Section 862, as amended, of the National Defense Authorization Act for Fiscal Year 2008;
10 U.S.C. 2302 Note). 
 __ (53) 52.226-4, Notice of Disaster or Emergency Area Set-Aside (Nov 2007) (42 U.S.C. 5150). 
 __
(54) 52.226-5, Restrictions on Subcontracting Outside Disaster or Emergency Area (Nov 2007) (42 U.S.C. 5150). 

__ (55) 52.229-12, Tax on Certain Foreign Procurements (Jun 2020). 

__ (56) 52.232-29, Terms for Financing of Purchases of Commercial Items (Feb 2002)
(41 U.S.C. 4505, 10 U.S.C. 2307(f)). 
 __ (57) 52.232-30, Installment
Payments for Commercial Items (Jan 2017) (41 U.S.C. 4505, 10 U.S.C. 2307(f)). 
 X__ (58) 52.232-33, Payment by Electronic Funds Transfer-System for Award Management (Oct 2018) (31 U.S.C. 3332). 

__ (59) 52.232-34, Payment by Electronic Funds Transfer-Other than System for Award Management (Jul 2013)
(31 U.S.C. 3332). 
 __ (60) 52.232-36, Payment by Third Party (May 2014)
(31 U.S.C. 3332). 
 __ (61) 52.239-1, Privacy or Security Safeguards (Aug 1996)
(5 U.S.C. 552a). 
 __ (62) 52.242-5, Payments to Small Business Subcontractors (Jan
2017) (15 U.S.C. 637(d)(13)). 
 __ (63) 52.247-64, Preference for Privately Owned
U.S.-Flag Commercial Vessels (Feb 2006) (46 U.S.C. Appx. 1241(b) and 10 U.S.C. 2631). 
 __ (ii) Alternate I (Apr
2003) of 52.247-64. 
 __ (iii) Alternate II (Feb 2006) of
52.247-64. 
 (End of clause) 

  
 8 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

 C.4 HHS Acquisition Regulations (HHSAR) 

This contract incorporates one or more HHSAR clauses by reference, with the same force and effect as if they were given in full text. The full text of a clause
may be accessed electronically at this/these address(es): 
 http://www.hhs.gov/ 

https://www.acquisition.gov/hhsar 
  

			
	 HHSAR SOURCE
	  	 TITLE AND DATE

	352.203-70	  	 Anti-Lobbying (Dec 2015)

	352.222-70	  	 Contractor Cooperation in Equal Employment Opportunity Investigations (Dec 2015)

	352.224-70	  	 Privacy Act (2015)

 C.5 Inspection and acceptance under this contract will be in accordance with FAR
52.212-4 Contract Terms and Conditions - Commercial Items (May 2015). 
 C.6 FAR 52.217-6 Option for Increased Quantity (Mar 1989) 
 The Government may increase the quantity of supplies called for in
the Schedule at the unit price specified. The Contracting Officer may exercise the option by written notice to the Contractor within 30 days. Delivery of the added items shall continue at the same rate as the like items called for under the
contract, unless the parties otherwise agree. 
 (End of Clause) 

C.7 FAR 52.217-7 Option for Increased Quantity-Separately Priced Line Item (Mar 1989) 

The Government may require the delivery of the numbered line item, identified in the Schedule as an option item, in the quantity and at the price stated in the
Schedule. The Contracting Officer may exercise the option by written notice to the Contractor within 15 days. Delivery of added items shall continue at the same rate that like items are called for under the contract, unless the parties
otherwise agree. 
 (End of clause) 
 C.8 FAR 52.217-8 Option to Extend Services (Nov 1999) 
 The Government may require continued performance of any services
within the limits and at the rates specified in the contract. These rates may be adjusted only as a result of revisions to prevailing labor rates provided by the Secretary of Labor. The option provision may be exercised more than once, but the total
extension of performance hereunder shall not exceed 6 months. The Contracting Officer may exercise the option by written notice to the Contractor within 15 days prior to expiration of the contract. 

(End of Clause) 

  
 9 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

 C.9 FAR 52.217-9 Option to Extend the Term of the Contract (Mar
2000) 
 (a) The Government may extend the term of this contract by written notice to the Contractor within 15 days of contract expiration;
provided, that the Government gives the Contractor a preliminary written notice of its intent to extend at least 15 days before the contract expires. The preliminary notice does not commit the Government to an extension. 

(b) If the Government exercises this option, the extended contract shall be considered to include this option clause. 

(c) The total duration of this contract, including the exercise of any options under this clause, shall not exceed 66 months. 

(End of Clause) 
 C. 10 CONTRACTING OFFICER’S
REPRESENTATIVE (COR) APPOINTMENT AND AUTHORITY 
 Performance of work under this contract is subject to the technical direction of the COR or a
representative designated by the contracting officer in writing. The term “technical direction” includes, without limitation, direction to the contractor that directs or redirects the labor effort, shifts the work between work areas or
locations, and/or fills in details and otherwise serves to ensure that tasks outlined in the contract are accomplished satisfactorily. Technical direction must be within the scope of the contract specification(s)/work statement. 

The COR does not have authority to issue technical direction that: (a) Constitutes additional work outside the contract specification(s) work statement;
(b) Constitutes a change as defined in the “Changes” clause of this contract; (c) Causes an increase or decrease in the contract price, or the time required for contract performance or interferes with the contractor’s right
to perform under the terms and conditions of the contract; or (d) Directs, supervises or otherwise controls the actions of the contractor’s employees. 

Technical direction may be oral or in writing. The COR must confirm oral direction in writing within five workdays, with a copy to the contracting officer.
The contractor shall proceed promptly with performance resulting from the technical direction issued by the COR. If, in the opinion of the contractor, any direction of the COR or the designated representative falls within the limitations above, the
Contractor shall immediately notify the Contracting Officer no later than the beginning of the next Government workday. Failure of the Contractor and the Contracting Officer to agree that technical direction is within the scope of the contract shall
be subjected the terms of the “Disputes” clause of this contract. 
 C.10 Invoice Submission 

 

	(a)	 Invoice Submission. 

  

	(b)	 The Contractor shall submit invoices once per month. 

 

	(c)	 A proper invoice, with all required back-up documentation shall be sent
electronically, via email, to the COR mailbox: 

  
 10 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

	(d)	 Contracting Officer’s Representative: Colton Maddox, [***]. 

 

	(e)	 A proper invoice, not including non-invoice related documents (i.e.
deliverables, reports, balance statements) shall be sent electronically, via email, to: 

  

	(f)	 Contract Specialist: Kimberly Golden; [***] 

 

	(g)	 Financial Management Service (FMS) via mailbox: [***] 

 

	(h)	 The subject line of your email invoice submission shall contain the contract number, order number (if
applicable), and the number of invoices. The Contractor shall send one email per contract per month. The email may have multiple invoices for the contract. Invoices must be in the following formats: PDF, TIFF, or Word. No Excel formats will be
accepted. The electronic file cannot contain multiple invoices; example, 10 invoices requires 10 separate files (PDF or TIFF or Word). 

  

	(i)	 Invoices shall be submitted in accordance with the contract terms, i.e. payment schedule, progress payments,
partial payments, deliverables, etc. 

  

	(j)	 All calls concerning contract payment shall be directed to the COR. 

 

	(k)	 Invoices will be handled in accordance with the Prompt Payment Act (31 U.S.C. 3903) and Office of Management
and Budget (OMB) prompt payment regulations at 5 CFR Part 1315. 

  

	(l)	 Invoice Elements. 

  

	(m)	 The Contractor shall submit an electronic invoice to the email addresses designated in the contract to receive
invoices. A proper invoice must include the following items: 

  

	(n)	 Name and address of the Contractor; 

 

	(o)	 Invoice date and number; 

 

	(p)	 Contract number, contract line item number and, if applicable, the order number; 

 

	(q)	 Description, quantity, unit of measure, unit price and extended price of the items delivered;

  

	(r)	 Shipping number and date of shipment, including the bill of lading number and weight of shipment if shipped on
Government bill of lading; 

  

	(s)	 Terms of any discount for prompt payment offered; 

 

	(t)	 Name and address of official to whom payment is to be sent; 

 

	(u)	 Name, title, and phone number of person to notify in event of defective invoice; and 

 

	(v)	 Taxpayer Identification Number (TIN). The Contractor shall include its TIN on the invoice only if required
elsewhere in this contract. 

  

	(w)	 Electronic funds transfer (EFT) banking information. 

 

	(x)	 The Contractor shall include EFT banking information on the invoice. 

 

	(y)	 In accordance with the requirements of the Debt Collection Improvement Act of 1996, all payments under this
order will be made by electronic funds transfer (EFT). The Contractor shall 

  

	(z)	 provide financial institution information to the Finance Office designated above in accordance with FAR 52.232-33 Payment by Electronic Funds Transfer - System for Award Management. 

  

	(aa)	 Additionally, the Program Support Center (PSC) requires: 

 

	(bb)	 the invoice to break-out price/cost by contract line item number
(CLIN) as specified in the pricing section of the contract the invoice to include the Dun & Bradstreet Number (DUNS) of the Contractor 

  
 11 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

 SECTION D – STATEMENT OF WORK 

Dialysis Care Hemodialysis System Lease, Maintenance & Training 

 

	D.1	 Background 

The mission of the Division of Strategic National Stockpile (DSNS), of the United States (U.S.) Department of Health and Human Services (HHS) Office
of the Assistant Secretary Preparedness and Response (ASPR), is to ensure the availability and rapid deployment of life-savings pharmaceuticals, antidotes, other medical supplies and equipment necessary to counter the effects of nerve agents,
biological pathogens, and chemical agents. When state, local, tribe and territorial public health and medical systems request federal assistance to support their response efforts, DSNS ensures that the right medicine and supplies get to those who
need them most during emergency. 
 The Strategic National Stockpile (SNS) is a national repository of large quantities of medicines, vaccines, medical
supplies, and medical equipment stored in strategic locations around the nation. The assets are designed to supplement state and local public health departments in the event of large-scale public health emergencies that cause local supplies to run
out. The objective is to address the needs of ASPR to support frail populations affected by natural and intentional disasters, and ensure that populations can be cared for in a manner that reduces the burden of transport, portable hemodialysis
capabilities need to be incorporated into Federal Medical System and Disaster Medical Assistance Team caches. 
  

	D.2	 Purpose & Scope 

The Coronavirus Disease 2019 (COVID-19) is a respiratory disease caused by infection with a new form of coronavirus (SARS-COV-2) has been detected in multiple locations around the world, including US COVID-19 has been declared a public health
emergency both within the United States and worldwide. As many as 30% of patients in the ICU being treated for COVID19 experience Acute Kidney Injury requiring life-maintaining dialysis for 14-21 days. The
majority require resource-intensive Hemodialysis and Continuous Renal Replacement Therapy (CRRT) 24 hours a day to address COVID severe complications. 

The purpose of this contract is to lease [***] FDA-approved, commercial dialysis platforms that can create their
own dialysate form potable sources, using standard 15A or 20A outlets to carry out hemodialysis treatments in temporary outpatient care facilities. ASPR is also seeking to procure a support cache of systems and materials, preventative maintenance
support, and training for ASPR Teams to deliver hemodialysis care in temporary outpatient centers. 
  

	D.3	 Requirement: The contractor shall provide the following services: 

 

	 	1.	 Lease [***] Dialysis Systems 

The contractor shall lease of [***] systems (new and/or refurbished) equipment, fully operational, assembled, tested, and configured to
include all associated cabling, plumbing and dialysis system consumables needed to distribute throughout the US to treat COVID19 patients at various hospitals and clinical settings, in addition to other public health emergencies for a period of
24 months. See section C.4 for Minimum Specifications. 

  
 12 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

	 	2.	 Shipping and Delivery 

The contractor shall ship and delivery all [***] Dialysis Systems and ancillary materials to CONUS and/or OCONUS (US Territory) locations. The
contractor shall perform the initial delivery of the units to the designated locations and pick-up the units upon lease expiration. 
  

	 	3.	 Installation and Maintenance 

 

	 	a.	 The contractor shall set up and install [***] Dialysis Systems and perform routine maintenance on up to
[***] USG-defined locations; provide hardware, software support and provide related consumables at up to [***] locations to ensure that the portable dialysis machines are operable and are ready for initial use
during a public health emergency. 

  

	 	b.	 The contractor shall inspect the equipment to make sure the units are fully operational, assembled, tested, and
configured. In addition, provide instruction manuals, cabling, plumbing and system relates consumables. 

  

	 	c.	 The contractor shall disinfect the portable dialysis systems daily by using heat disinfection and perform
chemical disinfection weekly while in deployment. 

  

	 	4.	 Training 

The contractor shall develop a curriculum standard training establishing a
train-the-trainer format. The curriculum shall be delivered in-person at USG-defined
locations up to [***] times a year. 
 The contractor shall develop a curriculum that includes: 

 

	 	a.	 Guidance on how to train healthcare providers in the operation and care of the portable dialysis systems.

  

	 	b.	 An established a curriculum for healthcare providers (inclusive of credentialed personnel and technicians) on
the operation and care of portable dialysis technologies. 

  

	 	c.	 Provides dialysate circuit overview, system setup guidance, disinfection, degassing, de-aeration, dialysate proportioning, formulation, dialysate modeling, dialysate monitoring, monitors, alarms and interventions, ultrafiltration, rinsing and contingency procedures (e.g. loss of power, loss of
water, etc.) training. 

  
 13 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

	 	5.	 Field Maintenance 

 

	 	a.	 The contractor shall conduct field maintenance and perform repairs on the portable dialysis systems transported
out in the field. The contractor shall be responsible for parts and labor for device services in the field at up to [***] CONUS and/or OCONUS (US Territory) locations. 

 

	 	b.	 The contractor shall maintain an operational availability of the platforms of at least [***]% at all locations.

  

	 	c.	 Components shall be shipped to a central location for repair within a [***]-hour period. The contractor shall
conduct additional intensive repairs, if needed. 

  

	 	d.	 The contractor shall pick up systems from a maximum of [***] readily accessible locations to perform repairs
and redeliver upon repair completion. 

  

	 	6.	 Hemodialysis Consumables (Surge) 

 

	 	a.	 The contractor shall provide all required consumables (e.g. to perform hemodialysis on all [***] deployed
platforms, assuming [***]-day per week clinical operation and up to [***] patients/system/day. 

Option to Increase Services: 
  

	 	7.	 Hemodialysis Consumables Surge of hemodialysis on deployed platforms, assuming [***]-day per week clinical operation and up to [***] patients/system/day 

  

	 	8.	 Shipping and Delivery Surge shipping and delivery of hemodialysis consumables materials to
CONUS/OCONUS locations. 

  

	 	9.	 Shipping and Delivery Surge 

The contractor shall ship and delivery Dialysis Systems and ancillary materials to OCONUS (US Territory) locations. 

D.4 Minimum Specifications: 
  

					
	Dialysis Treatment	  	[***]	  	[***]
		  	 [***]
	  	 [***]

		  	 [***]
	  	 [***]

		  	 [***]
	  	 [***]

		  	 [***]
	  	 [***]

		  	 [***]
	  	 [***]

		  	 [***]
	  	 [***]

		  	 [***]
	  	 [***]

		  	 [***]
	  	 [***]

		  	 [***]
	  	 [***]

			
		  	 [***]
	  	 [***]

		  	 [***]
	  	 [***]

		  	 [***]
	  	 [***]

  
 14 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

	D.5	 Contract Period of Performance 

The Government has a requirement to acquire these items and services for both response to public health events, and preparedness. The period of performance
will be 24 months from the date of award. 
  

	D.6	 Deliverables 

 

					
	 Deliverable
	  	 Format/Deliver to
	  	 Date

			
	Kick-Off Meeting Notes	  	Electronic copy of Kick-Off Meeting Notes – COR	  	[***]
			
	 System Delivery:
 Delivery of dialysis
platforms to GVT-specified locations. This will be new and/or and refurbished equipment, fully operational, assembled, tested, and configured to include all associated instruction manuals,
cabling, plumbing
	  	Email confirmation to COR/POC	  	[***]
			
	 Training Curriculum:
 Curriculum for
healthcare providers (inclusive of credentialed personnel and technicians) for operation and care of portable dialysis technologies.
	  	Curriculum emailed to COR/POC	  	[***]
			
	 Training:
 Training curriculum above
delivered to first set of personnel
	  	Training delivered at ASPR defined locations	  	[***]
			
	 Routine Maintenance:
 Provided by
contractor within up to [***] USG-Controlled locations Includes weekly chemical disinfection, filter replacement and other routine maintenance as required.
	  	Email confirmation to COR/POC	  	[***]

  
 15 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

					
			
	 Field Maintenance:
 Provide maintenance
of up to [***] systems in up to [***] locations, or components shipped to central depot(s) for repair. Contractor must maintain an operational availability of at least 90%
	  	Email confirmation to COR/POC	  	[***]
			
	 Consumables:
 The contractor shall
provide all required consumables to perform hemodialysis on all [***] deployed platforms, assuming [***]-day per week clinical operation and up to [***] patients/system/day.
	  	Email confirmation to COR/POC	  	[***]
			
	 Quarterly Reports:
 The report will have
two (2) major sections.
 1. Technical Status Report. The technical status report will detail technical reports on all problems, technical issues, major
developments, and the status of equipment during the reporting period.
 2. Business Status Report. The business status report shall provide summarized
details of the resource status, and a quarterly accounting of current expenditures.
	  	Emailed to COR/POC	  	[***]
			
	 Special Technical Reports:
 The
contractor shall electronically submit or otherwise provide to the COR and CO special reports on significant events such as significant target accomplishments, significant equipment tests, failures, significant issues with consumables, or
significant delivery issues.
	  	Email to CO/COR/POC	  	[***]

  
 16 of 17 

 *Portions of this exhibit have been excluded because it both (i) is not material and (ii) would be
competitively harmful if publicly disclosed. 
  

					
			
	 Final Report:
 The contractor shall
electronically submit a Final Report making full disclosure of all major deliverables. The Final Report shall be marked with a distribution statement to denote the extent of its availability for distribution, release, and disclosure without
additional approvals or authorizations. The Final Report shall be marked on the front page in a conspicuous place with the following marking:
  

“DISTRIBUTION STATEMENT. Distribution authorized to U.S. Government agencies only to protect information not owned by the U.S. Government and
protected by a Contractor’s “limited rights” statement, or received with the understanding that it not be routinely transmitted outside the U.S. Government. Other requests for this document shall be referred to HHS/CO.”
	  	Email to copy CO/COR/POC	  	[***]

  
 17 of 17Exhibit 10.1

 

TRANSITION,
SEPARATION AND RELEASE AGREEMENT

 

This
Transition, Separation and Release Agreement (this “Agreement”), delivered August 10, 2020 (the
“Offer Date”), confirms the following understandings and agreements between AdaptHealth Corp. (the “Company”)
and Gregg Holst (hereinafter referred to as “you” or “your”).

 

In consideration
of the promises set forth herein, you and the Company agree as follows:

 

1.            Opportunity
for Review; Acceptance.

 

(a)           You
have until August 31, 2020 (the “Review Period”), to review and consider this Agreement. To accept
this Agreement, and the terms and conditions contained herein, prior to the expiration of the Review Period, you must execute
and date this Agreement where indicated below and return the executed copy of this Agreement to Christopher Joyce, General Counsel
(the “Company Representative”). You acknowledge that, to the extent there are changes made to the terms
of this Agreement, whether they are material or immaterial, the Review Period is not recommenced.

 

(b)           Notwithstanding
anything contained herein to the contrary, this Agreement will not become effective or enforceable for a period of seven
(7) calendar days following the date of your execution of this Agreement (the “Revocation
Period”), during which time you may revoke your acceptance of this Agreement by notifying the Company
Representative, in writing, as specified above. To be effective, such revocation must be received by the Company
Representative no later than 5:00 p.m. Eastern Time on the seventh (7th) calendar day following your
execution of this Agreement. Provided that this Agreement is executed during the Review Period and you do not revoke it
during the Revocation Period, the eighth (8th) day following the date on which this Agreement is executed and
delivered to the Company Representative shall be its effective date (the “Effective Date”). In the
event that you fail to execute and deliver this Agreement prior to the expiration of the Review Period or otherwise revoke
this Agreement during the Revocation Period, this Agreement will be null and void and of no effect, and neither the Company
nor any other member of the Company Group (as defined below) will have any obligations hereunder.

 

2.            Employment
Status; Accrued Benefits; Transition Period; Separation Benefits.

 

(a)           Employment
Status. You acknowledge and agree that your employment with the Company and its direct and indirect subsidiaries, and affiliates
(collectively, with the Company, the “Company Group”), will terminate effective as of the close of business
on September 1, 2020 (the “Separation Date”). You will not represent yourself as being an employee,
officer, agent, or representative of the Company or any other member of the Company Group after the Separation Date. During the
period between the Offer Date and the Separation Date, you will remain on the Company’s active payroll, be paid your current
salary in accordance with the Company’s regular payroll practices, and continue to participate in all employee benefit plans
and other programs or arrangements sponsored by or through the Company and any other member of the Company Group in which you
are eligible to participate (the “Benefit Plans”). You hereby confirm your resignations from all offices,
directorships, trusteeships, committee memberships and fiduciary and other capacities held with, or on behalf of, the Company
Group effective as of August 3, 2020 (the “Transition Date”) and your execution of this Agreement
will be deemed the grant by you to the officers of the Company of a limited power of attorney to sign in your name and on your
behalf any such documentation as may be required to be executed solely for the limited purposes of effectuating such resignations.
You agree that within five (5) business days following the Effective Date, you will update your accounts or profiles on any
social media platform (including, but not limited to, Facebook, Twitter or LinkedIn) to reflect that you are no longer actively
employed by the Company.

 

     

     

    

 

(b)           Accrued
Benefits. The Separation Date shall be the termination date of your employment for purposes of participation in and coverage
under all Benefit Plans, except as otherwise provided herein. You will be paid for (i) all of your earned but unpaid salary
through the Separation Date on or prior to the Company’s next regularly scheduled payroll date on or following the Separation
Date, or earlier to the extent otherwise required by applicable law, (ii) your accrued but unused vacation as of the Separation
Date to the extent required by the Company’s policies, payable on or prior to the Company’s next regularly scheduled
payroll date on or following the Separation Date; and (iii) any business expenses incurred prior to the Separation Date and
properly submitted in accordance with the Company’s policies and procedures within ten (10) days following the Separation
Date. In addition, you will be entitled to continued medical and health benefits under the Consolidated Omnibus Budget Reconciliation
Act of 1985 (“COBRA”), and additional information concerning such benefits will be provided to you under
separate cover following the Separation Date.

 

(c)           Transition
Period. During the period between the Transition Date and the Separation Date (the “Transition Period”),
you agree to cooperate with the Company and/or any other member of the Company Group, provide information, answer questions and
provide guidance as requested from time to time relating to any matter on which you will have worked prior to the Transition Date
or of which you have knowledge. You shall perform your duties during the Transition Period on a full-time basis at such location
or locations as may be reasonably determined by the Company.

 

(d)           Separation
Benefits. In consideration of your release and waiver of claims set forth in Section 3 below and in the reaffirmation
of this Agreement in the form attached hereto as Exhibit A (the “Reaffirmation”), and subject
to your execution, delivery and non-revocation of this Agreement and continued compliance with this Agreement, including but not
limited to Section 11 and Section 12 hereof, the Company will provide you with the following separation benefits (collectively,
the “Consideration”):

 

(1)        Separation
Payment. Payment of $500,000 in substantially equal installments over a period of twelve (12) months in accordance with the
Company’s regular payroll practices, commencing on the first regularly scheduled payroll date following the Reaffirmation
Effective Date (as defined in the Reaffirmation); and

 

(2)        COBRA.
At the expense of the Company and subject to your timely election of COBRA continuation coverage, continuation of your enrollment
under the Company’s group health insurance plan as of the Separation Date during the period beginning on the Separation
Date and ending on June 30, 2023, subject to the same coverage limits, deductibles, co-insurance provisions and other terms
and conditions as existed while you were employed by the Company,; provided, that the coverage pursuant to this Section 2(d)(2) shall
cease earlier June 30, 2023 in the event that you become eligible to receive any health benefits as a result of subsequent
employment or service with any other person or entity or otherwise (which such eligibility shall be promptly reported by you to
the Company). Notwithstanding the immediately preceding sentence, the Company’s payment of the COBRA premiums during the
period from the Separation Date through June 30, 2023 will be taxable to you.

 

    - 2 -

     

    

 

(e)            Deferral
of Payments. Notwithstanding the foregoing, in the event that any amount would otherwise have been payable as a result of
Section 2(d) prior to the Reaffirmation Effective Date, such amount shall not be paid until the first regular payroll
date following the Reaffirmation Effective Date.

 

(f)            Full
Discharge. You acknowledge and agree that the payment(s) and other benefits provided pursuant to this Section 2
are in full discharge of any and all liabilities and obligations of the Company or any other member of the Company Group to you,
monetarily or with respect to employee benefits or otherwise, including but not limited to any and all obligations arising under
the Employment Agreement between you and AdaptHealth, LLC, dated November 10, 2014 (the “Employment Agreement”),
any other alleged written or oral employment agreement, policy, plan or procedure of the Company or any other member of the Company
Group and/or any alleged understanding or arrangement between you and the Company or any other member of the Company Group (other
than claims for accrued and vested benefits under an employee benefit, insurance, or pension plan of the Company or any other
member of the Company Group (excluding any severance or similar plan or policy), subject to the terms and conditions of such plan(s)).

 

(g)           Taxes.
The Consideration is subject to withholding for all applicable taxes, including but not limited to income, employment, and
social security taxes, as shall be required by law.

 

3.            Release
and Waiver of Claims.

 

(a)           As
used in this Agreement, the term “claims” will include all claims, covenants, warranties, promises, undertakings,
actions, suits, causes of action, obligations, debts, accounts, attorneys’ fees, judgments, losses and liabilities, of whatsoever
kind or nature, in law, equity or otherwise.

 

(b)           For
and in consideration of the payments and benefits described in Section 2 above, and other good and valuable consideration,
you, for and on behalf of yourself and your heirs, administrators, executors and assigns, as of the date hereof, do fully and
forever release, remise and discharge each member of the Company Group and their successors and assigns, together with their respective
officers, directors, partners, members, stockholders (including any management company of a stockholder), employees and agents
(collectively, and with the Company, the “Company Parties”) from any and all claims whatsoever up to
the date hereof which you had, may have had, or now have against the Company Parties, whether known or unknown, for or by reason
of any matter, cause or thing whatsoever, including any claim arising out of or attributable to your employment or the termination
of your employment with the Company or any member of the Company Group, whether for tort, breach of express or implied employment
contract, intentional infliction of emotional distress, wrongful termination, unjust dismissal, defamation, libel or slander,
or under any federal, state or local law dealing with discrimination based on age, race, sex, national origin, handicap, religion,
disability or sexual orientation. This release of claims includes, but is not limited to, all claims arising under the Age Discrimination
in Employment Act (the “ADEA”), Title VII of the Civil Rights Act of 1964, the Americans with Disabilities
Act, the Civil Rights Act of 1991, the Family and Medical Leave Act, the Equal Pay Act, the Worker Adjustment and Retraining Notification
Act, and the Employee Retirement Income Security Act (excluding claims for accrued, vested benefits under an employee pension
benefit plan of the Company Parties), each as may be amended from time to time, and all other federal, state and local laws, the
common law and any other purported restriction on an employer’s right to terminate the employment of employees. You intend
the release contained herein to be a general release of any and all claims to the fullest extent permissible by law and for the
provisions regarding the release of claims against the Company Parties to be construed as broadly as possible, and hereby incorporate
in this release similar federal, state or other laws, all of which you also hereby expressly waive.

 

    - 3 -

     

    

 

(c)           You
understand and agree that claims or facts in addition to or different from those which are now known or believed by you to exist
may hereafter be discovered, but it is your intention to fully and forever release, remise and discharge all claims which you
had, may have had, or now have against the Company Parties, whether known or unknown, suspected or unsuspected, asserted or unasserted,
contingent or noncontingent, without regard to the subsequent discovery or existence of such additional or different facts. Without
limiting the foregoing, by signing this Agreement, you expressly waive and release any provision of law that purports to limit
the scope of a general release.

 

(d)           You
acknowledge and agree that as of the date you execute this Agreement, you have no knowledge of any facts or circumstances that
give rise or could give rise to any claims under any of the laws listed in the preceding paragraphs.

 

(e)            Notwithstanding
any provision of this Agreement to the contrary, by executing this Agreement, you are not releasing any claims relating to: (i) your
rights with respect to payment of the Consideration, (ii) your right to accrued, vested benefits due to terminated employees
under any employee benefit plan of the Company or any other member of the Company Group in which you participated (excluding any
severance or similar plan or policy), in accordance with the terms thereof (including your right to elect COBRA continuation coverage),
(iii) any claims that cannot be waived by law or that arise after the date on which you execute this Agreement; (iv) your
right to indemnification, advancement and reimbursement of legal fees and expenses, and directors and officers liability insurance,
as provided by, and in accordance with the terms of, applicable law, the Company’s by-laws or otherwise; (v) any rights
or claims under the ADEA that may arise after the date that you execute this Agreement; (vi) your rights as a stockholder
of the Company or as a member of AdaptHealth LLC; or (vi) any rights or claims arising out of facts, events or matters occurring
after the date that you execute this Agreement.

 

(f)            You
acknowledge and agree that, by virtue of the foregoing, you have waived any relief available to you (including without limitation,
monetary damages, equitable relief and reinstatement) under any of the claims and/or causes of action waived in this Section 3.
Therefore you agree that you will not accept any award or settlement from any source or proceeding (including but not limited
to any proceeding brought by any other person or by any government agency) with respect to any claim or right waived in this Agreement.

 

    - 4 -

     

    

 

(g)            You
acknowledge and agree that as of the date of this Agreement, you have reported all accidents, injuries or illnesses relating to
or arising from your employment with the Company or the Company Group and that you have not suffered any on-the-job injury or
illness for which you have not yet filed a claim.

 

4.            Knowing
and Voluntary Waiver. You expressly acknowledge and agree that you:

 

(a)            are
able to read the language, and understand the meaning and effect, of this Agreement;

 

(b)            have
no physical or mental impairment of any kind that has interfered with your ability to read and understand the meaning of this
Agreement or its terms, and that you are not acting under the influence of any medication, drug or chemical of any type in entering
into this Agreement;

 

(c)            are
specifically agreeing to the terms of the release contained in this Agreement because the Company has agreed to provide you the
Consideration, which the Company has agreed to provide because of your agreement to accept it in full settlement of all possible
claims you might have or ever had, and because of your execution of this Agreement;

 

(d)           acknowledge
that but for your execution of this Agreement, you would not be entitled to the Consideration;

 

(e)            had
or could have the entire Review Period in which to review and consider this Agreement, and that if you execute this Agreement
prior to the expiration of the Review Period, you have voluntarily and knowingly waived the remainder of the Review Period;

 

(f)             understand
that, by entering into this Agreement, you do not waive rights or claims under the ADEA that may arise after the date you execute
this Agreement;

 

(g)            have
not relied upon any representation or statement not set forth in this Agreement made by the Company Group or any of its representatives;

 

(h)            were
advised to consult with your attorney regarding the terms and effect of this Agreement; and

 

(i)             have
signed this Agreement knowingly and voluntarily.

 

5.            No
Suit. You represent and warrant that you have not previously filed, and to the maximum extent permitted by law agree that
you will not file, a complaint, charge or lawsuit against any of the Company Parties regarding any of the claims released herein.
If, notwithstanding this representation and warranty, you have filed or file such a complaint, charge or lawsuit, you agree that
you shall cause such complaint, charge or lawsuit to be dismissed with prejudice and shall pay any and all costs required in obtaining
dismissal of such complaint, charge or lawsuit, including without limitation the attorneys’ fees of any of the Company Parties
against whom you have filed such a complaint, charge, or lawsuit. Notwithstanding anything to the contrary, nothing herein shall
prevent or restrict you from (i) filing a charge or complaint with, participating in an investigation or proceeding conducted
by, or reporting possible violations of law or regulation to any federal, state or local government agency; (ii) truthfully
responding to or complying with a subpoena, court order, or other legal process; or (iii) exercising any rights you may have
under applicable labor laws to engage in concerted activity with other employees; provided, however, that you hereby
forgo any monetary benefit from the filing of a charge or complaint with a government agency except pursuant to a whistleblower
program or where my right to receive such a monetary benefit is otherwise not waivable by law.

 

    - 5 -

     

    

 

6.            Reaffirmation
of Separation Agreement. You agree to execute the Reaffirmation on or after the Separation Date and to deliver the executed
Reaffirmation to the Company Representative on or after the Separation Date. You agree that all Company covenants that relate
to its obligations beyond the Separation Date are contingent on your execution, delivery and non-revocation of the Reaffirmation.

 

7.            Indemnification.
In the event you are named or threatened to be named in any lawsuit or other proceeding arising out of your work for the Company
or for any predecessor, the Company will indemnify, defend and hold you harmless to the fullest extent permitted by law from all
damages and losses incurred by you as a result of such lawsuit or proceeding, including but not limited to (i) all liability
by way of settlement, verdict, judgment or otherwise, and (ii) all attorney’s fees and litigation expenses. This right
of indemnity shall be in addition to any right of indemnity you have or may have under applicable law, the Company’s by-laws
or other organizational documents, or the Company’s liability insurance.

 

8.            No
Re-Employment. You hereby agree to waive any and all claims to re-employment with the Company or any other member of the Company
Group. You affirmatively agree not to seek further employment with the Company or any other member of the Company Group. You acknowledge
that if you re-apply for or seek employment with the Company or any other member of the Company Group, the Company’s or
any other member of the Company Group’s refusal to hire you based on this provision will provide a complete defense to any
claims arising from your attempt to apply for employment.

 

9.            Successors
and Assigns. The provisions hereof shall inure to the benefit of your heirs, executors, administrators, legal personal representatives
and assigns and shall be binding upon your heirs, executors, administrators, legal personal representatives and assigns.

 

10.          Severability;
Third-Party Beneficiaries. If any provision of this Agreement shall be held by any court of competent jurisdiction to be illegal,
void or unenforceable, such provision shall be of no force and effect. The illegality or unenforceability of such provision, however,
shall have no effect upon and shall not impair the enforceability of any other provision of this Agreement. You acknowledge and
agree that each of the Company Parties shall be a third-party beneficiary to the releases set forth in Section 3 above, with
full rights to enforce this Agreement and the matters documented herein.

 

    - 6 -

     

    

 

11.          Cooperation.

 

(a)           You
agree that you will provide reasonable cooperation to the Company and/or any other member of the Company Group and its or their
respective counsel in connection with any investigation, administrative proceeding or litigation relating to any matter that occurred
during your employment in which you were involved or of which you have knowledge. The Company agrees to reimburse you for reasonable
out-of-pocket expenses incurred at the request of the Company with respect to your compliance with this Section 11(a).

 

(b)           You
agree that, in the event you are subpoenaed by any person or entity (including, but not limited to, any government agency) to
give testimony or provide documents (in a deposition, court proceeding or otherwise) which in any way relates to your employment
by the Company and/or any other member of the Company Group, you will give prompt written notice of such request to the Company
Representative, in writing, as specified above (or the Company Representative’s successor or designee) and will, if permitted
by the terms of the subpoena, make no disclosure until the Company and/or the other member of the Company Group has had a reasonable
opportunity to contest the right of the requesting person or entity to such disclosure. The Company agrees to reimburse you for
reasonable out-of-pocket expenses incurred at the request of the Company with respect to your compliance with this Section 11(b).

 

12.          Affirmation
of Continuing Obligations. You hereby acknowledge and agree that the execution of this Agreement does not alter your obligations
to any member of the Company Group under any confidentiality, non-compete, non-solicit, non-disparagement, invention assignment,
or similar agreement or arrangement to which you are a party with any member of the Company Group (including, without limitation,
the obligations set forth in Section 5 of the Employment Agreement) (the “Restrictive Covenants”),
which obligations are hereby incorporated into this Agreement and shall survive the termination of your employment with the Company,
and you hereby acknowledge, reaffirm and ratify your continuing obligations to the Company Group pursuant to such agreements or
arrangements. You further hereby acknowledge that your continued compliance with these obligations is a condition of your receiving
the Consideration described in Section 2 above and upon any breach of the Restrictive Covenants, the Company shall be entitled
to an immediate refund of any Consideration already received by you.

 

13.          Confidentiality.
The terms and conditions of this Agreement are and shall be deemed to be confidential, and shall not be disclosed by you to any
person or entity without the prior written consent of the Company, except (i) if required by law, (ii) in connection
with any action to enforce this Agreement, (iii) to a lender in connection with a bona fide loan application, and/or (iv) to
your accountants, attorneys and/or immediate family, provided that, to the maximum extent permitted by applicable law, rule, code
or regulation, they agree to maintain the confidentiality of this Agreement.

 

14.          Return
of Property. You agree that you will promptly return to the Company, and you will retain no copies of, all property belonging
to the Company and/or any other member of the Company Group, including but not limited to all proprietary and/or confidential
information and documents (including any copies thereof) in any form belonging to the Company, cell phone, Blackberry, iPhone
or other mobile device, keys, credit card, identification card or badge, access card, employee handbook, laptop, computer or other
office equipment, computer user name and password, disks, data files, thumb drives, and/or voicemail code. If you discover after
the Separation Date that you have retained any proprietary and/or confidential information (including, without limitation, proprietary
and/or confidential information contained in any electronic documents or email systems in your possession or control), you agree
immediately upon discovery to send an email to the Company Representative to inform the Company of the nature and location of
the proprietary and/or confidential information that you have retained so that the Company may arrange to remove, recover, and/or
collect such information. You further acknowledge and agree that the Company shall have no obligation to provide the Consideration
described in Section 2 above unless and until you have satisfied all your obligations pursuant to this Section 14. Nothing
in this Section 14 shall prevent you from retaining: (i) compensation-related information and copies of benefit plans
and programs in which you retain an interest and such other records and documents reasonably necessary for tax-preparation purposes
or as may be expressly approved by the Company; (ii) personal office furnishings; (iii) your contacts, calendars and
personal diaries; or (iv) Company-issued computers and mobile devices provided that you first tender the devices to the Company
to have all proprietary and/or confidential information removed.

 

    - 7 -

     

    

 

15.          Non-Admission.
Nothing contained in this Agreement will be deemed or construed as an admission of wrongdoing or liability on the part of you
or any member of the Company Group. Accordingly, this Agreement may not be admissible in any forum as an admission, but only in
an action to enforce it.

 

16.          Entire
Agreement. This Agreement and the Restrictive Covenants constitute the entire understanding and agreement of the parties hereto
regarding the termination of your employment. This Agreement and the Restrictive Covenants supersede all prior negotiations, discussions,
correspondence, communications, understandings and agreements between the parties relating to the subject matter of this Agreement
and the Restrictive Covenants.

 

17.          Governing
Law; Jurisdiction; Arbitration. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH FEDERAL LAW AND THE LAWS
OF THE COMMONWEALTH OF PENNSYLVANIA, APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN THAT COMMONWEALTH, WITHOUT REGARD TO
CONFLICT OF LAWS RULES. BY EXECUTION OF THIS AGREEMENT, EACH PARTY TO THIS AGREEMENT HEREBY CONSENTS TO THE EXCLUSIVE JURISDICTION
OF THE COMMONWEALTH AND FEDERAL COURTS LOCATED IN THE COMMONWEALTH OF PENNSYLVANIA AND HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY
IN CONNECTION WITH ANY DISPUTE ARISING UNDER OR CONCERNING THIS AGREEMENT. ALL DISPUTES ARISING UNDER OR CONCERNING THIS AGREEMENT,
AS WELL AS ALL CLAIMS ARISING OUT OF YOUR EMPLOYMENT OR TERMINATION THEREOF, INCLUDING WITHOUT LIMITATION ALL CLAIMS FOR
PAYMENT OF WAGES, DISCRIMINATION, RETALIATION, AND ALL OTHER CLAIMS BASED ON ANY STATE, FEDERAL OR COMMON LAW WILL BE RESOLVED
THROUGH BINDING ARBITRATION BEFORE A SINGLE ARBITRATOR. THE ARBITRATION SHALL BE ADMINISTERED BY JAMS, UNDER ITS THEN APPLICABLE
RULES FOR EMPLOYMENT DISPUTES. IF JAMS CANNOT SERVE AS THE ARBITRATION ADMINISTRATOR, THEN THE ARBITRATION WILL BE THROUGH THE
AMERICAN ARBITRATION ASSOCIATION, UNDER ITS THEN APPLICABLE RULES FOR EMPLOYMENT DISPUTES. THE EXCLUSIVE VENUE OF ANY SUCH ARBITRATION
WILL BE PLYMOUTH MEETING, PENNSYLVANIA. THE NON-PREVAILING PARTY WILL PAY THE REASONABLE ATTORNEYS’ FEES AND COSTS OF THE
PREVAILING PARTY. THE ARBITRATOR SHALL HAVE AUTHORITY TO ISSUE EQUITABLE AND LEGAL RELIEF, INCLUDING WITHOUT LIMITATION INJUNCTIVE
RELIEF AND MONETARY DAMAGES. ALL ARBITRATION PROCEEDINGS SHALL BE CONFIDENTIAL.

 

    - 8 -

     

    

 

18.          Construction.
The section or paragraph headings or titles herein are for convenience of reference only and shall not be deemed a part of this
Agreement. The parties hereto acknowledge and agree that each party has reviewed and negotiated the terms and provisions of this
Agreement and has had the opportunity to contribute to its revision. Accordingly, the rule of construction to the effect
that ambiguities are resolved against the drafting party shall not be employed in the interpretation of this Agreement. Rather,
the terms of this Agreement shall be construed in a reasonable manner to effect the intentions of both parties hereto and not
in favor or against either party.

 

19.          Section 409A.
Payments under this Agreement are intended to be exempt from, or comply with, Section 409A of the Internal Revenue Code of
1986, as amended (“Section 409A”), and this Agreement will be interpreted to achieve this result.
For purposes of this Agreement, each payment in a series of payments hereunder shall be deemed to be a separate payment for purposes
of Section 409A. In no event is the Company responsible for any tax or penalty owed by you (other than for withholding obligations
or other obligations applicable to employers, if any, under Section 409A) with respect to payments under this Agreement.

 

20.          Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which shall constitute one
and the same instrument, and electronically delivered copies of executed counterparts shall be deemed to be originals for all
purposes.

 

*           *          *

 

    - 9 -

     

    

 

IN WITNESS
WHEREOF, the parties hereto have executed this Agreement as of the date set forth below.

 

	 	ADAPTHEALTH CORP.
	 	 
	 	
	 	By:	/s/ Luke
    McGee
	 	Name: Luke McGee
	 	Title: Chief Executive
    Officer
	 	 
	 	 
	 	GREGG HOLST
	 	 
	 	 
	 	/s/ Gregg Holst
	 	Gregg Holst
	 	Dated: August 18, 2020

 

[Signature Page to G.
Holst Transition, Separation and Release Agreement]

 

     

     

    

 

Exhibit A

 

REAFFIRMATION OF SEPARATION
AGREEMENT

 

By signing
this Reaffirmation of Separation Agreement (this “Reaffirmation”), I confirm and reaffirm my understanding
and agreement to the commitments set forth in my Transition, Separation and Release Agreement (the “Separation Agreement”),
dated August 10, 2020, with AdaptHealth Corp. (the “Company”) as of the Separation Date (as defined
in the Separation Agreement) or the date that I sign this Reaffirmation if such date is later (the “Reaffirmation
Effective Date”), and my agreement that I have received and will receive consideration in exchange for the commitments
set forth in the Separation Agreement. By signing and dating in the space provided below, I confirm my acceptance of the
severance package offered to me by the Company.

 

I hereby ratify and reaffirm
the commitments set forth in the Separation Agreement as of the Separation Date or the date I sign this reaffirmation if such
date is later.

 

	 	 
	 	GREGG HOLST
	 	 
	 	Dated:                                             

 

Please
sign and date the above on or after the Separation Date, and return one signed Reaffirmation to the Company Representative
(as defined in the Separation Agreement). After this signed document is received by the Company, the Company will pay the Consideration
(as defined in the Separation Agreement) in accordance with the terms of the Separation Agreement.

 

[Signature Page to G.
Holst Reaffirmation of Separation Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]